13.06.2024 - SOUTH SAN FRANCISCO, June 13, 2024 (GLOBE NEWSWIRE) - Pliant Therapeutics, Inc. (Nasdaq: PLRX), a late-stage biotechnology company and leader in the discovery and development of novel therapeutics for the treatment of fibrotic diseases, today . Seite 1
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) shares saw strong trading volume on Wednesday . 2,015,233 shares traded hands during trading, an increase of 76% from the previous session’s volume of 1,148,126 shares.The stock last traded at $22.39 and had previously closed at $21.60. Wall Street Analyst Weigh In A number of equities research […]
Denali Therapeutics Inc. (NASDAQ:DNLI – Get Free Report) Director Jennifer E. Cook sold 1,458 shares of the stock in a transaction on Thursday, June 6th. The stock was sold at an average price of $21.73, for a total transaction of $31,682.34. Following the transaction, the director now owns 20,038 shares in the company, valued at […]
What Endowments and Foundations Are Most Worried About Right Now institutionalinvestor.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from institutionalinvestor.com Daily Mail and Mail on Sunday newspapers.
New therapeutic approach for frontotemporal dementia uses modified viruses to replace a missing protein in the brain medicalxpress.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from medicalxpress.com Daily Mail and Mail on Sunday newspapers.